Results Snapshot
Quarterly Analysis Highlights - QoQ
Net Sales
QoQ Growth in quarter ended Sep 2025 is -14.51% vs -1.91% in Jun 2025
Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -37.55% vs 89.02% in Jun 2025
Operating Profit (PBDIT) excl Other Income
QoQ Growth in quarter ended Sep 2025 is -60.93% vs 62.96% in Jun 2025
Interest
QoQ Growth in quarter ended Sep 2025 is -33.33% vs 0.00% in Jun 2025
Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
Compare Quarterly Results Of Beijing Aosaikang Pharmaceutical Co., Ltd. With
Quarterly - Net Sales
QoQ Growth in quarter ended Sep 2025 is -14.51% vs -1.91% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -7.66% vs 13.24% in Sep 2024
Quarterly - Consolidate Net Profit
QoQ Growth in quarter ended Sep 2025 is -37.55% vs 89.02% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 33.48% vs 215.35% in Sep 2024
Quarterly - Operating Profit (PBDIT)
QoQ Growth in quarter ended Sep 2025 is -60.93% vs 62.96% in Jun 2025
YoY Growth in quarter ended Sep 2025 is -34.30% vs 328.57% in Sep 2024
Quarterly - Interest
QoQ Growth in quarter ended Sep 2025 is -33.33% vs 0.00% in Jun 2025
YoY Growth in quarter ended Sep 2025 is 0.00% vs -100.00% in Sep 2024
Quarterly - Operating Profit Margin (Excl OI)
QoQ Growth in quarter ended Sep 2025 has fallen from Jun 2025
YoY Growth in quarter ended Sep 2025 has improved from Sep 2024






